
Moncef Slaoui — the ex-head of GlaxoSmithKline’s vaccines division who was appointed by President Trump to lead the US's coronavirus vaccine effort — said he is confident a vaccine will be developed by the end of 2020.
"I have very recently seen early data from a clinical trial with a coronavirus vaccine and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020 and we will do the best we can," he said at a news conference with Trump on Friday.
In addition to a vaccine, he said operation "warp speed" will also focus on the development of medicines for those who are already infected as well as improving and "optimizing" diagnostic tests.
"It is a great honor to serve our country and the world in this remarkable endeavor," Slaoui said.
Watch: